Therapeutic Targets to Raise HDL in Patients at Risk or with Coronary Artery Disease

E-ISSN： 1875-6212|10|6|720-724

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.6, 2012-11, pp. : 720-724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)

By Zhao X.-Q. Morse J.S. Dowdy A.A. Heise N. DeAngelis D. Frohlich J. Chait A. Albers J.J. Brown B.G.

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 307-312

Elsevier

Access to resources Recommend Favorite

Bivalirudin in Patients with Coronary Artery Disease

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 8, Iss. 4, 2010-10 ,pp. : 199-203

Bentham Science Publishers

Access to resources Recommend Favorite

Why is the Inhibition of the Renin-Angiotensin System Effective for Preventing Cardiac Events in Patients with Coronary Risk Factors or Coronary Artery Disease?

Current Cardiology Reviews, Vol. 2, Iss. 4, 2006-11 ,pp. : 293-316

Bentham Science Publishers

Access to resources Recommend Favorite

Myeloproliferative syndromes and the associated risk of coronary artery disease

By Ganti A.K. Potti A. Koka V.K. Pervez H. Mehdi S.A.

Thrombosis Research, Vol. 110, Iss. 2, 2003-05 ,pp. : 83-86

Elsevier

Access to resources Recommend Favorite

Coronary artery disease screening in patients with diabetes

By Savarese Vincent

Endocrine Journal, Vol. 33, Iss. 3, 2008-06 ,pp. : 225-229

Humana Press, Inc

Access to resources Recommend Favorite